Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma

被引：0
|
作者：
Hanno M. Witte
Armin Riecke
Thomas Mayer
Tobias Bartscht
Dirk Rades
Hendrik Lehnert
Hartmut Merz
Sebastian Fetscher
Harald Biersack
Niklas Gebauer
机构：
[1] University Hospital of Schleswig-Holstein (UKSH),Department of Haematology and Oncology
[2] German Armed Forces Hospital Ulm,Department of Haematology and Oncology
[3] University Hospital of Schleswig-Holstein,Department of Radiation Oncology
[4] University Hospital of Schleswig-Holstein,Department of Internal Medicine I
[5] Reference Center for Lymph Node Pathology and Haematopathology,Department of Haematology and Oncology
[6] Sana Hospitals,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Trofosfamide; Diffuse large B-cell lymphoma; Elderly; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 136
页数：7
相关论文
共 50 条
  • [21] Should age influence treatment options in elderly patients with diffuse large B-cell lymphoma?
    Clark, Cameron
    Turner, Catherine
    Morley, Nick
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 182 - 182
  • [22] Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma
    Cheng, Chieh-Lung
    Liu, Jia-Hau
    Chou, Sheng-Chieh
    Yao, Ming
    Tang, Jih-Luh
    Tien, Hwei-Fang
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 28 - 37
  • [23] Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives
    Chiappella, Annalisa
    Castellino, Alessia
    Nicolosi, Maura
    Santambrogio, Elisa
    Vitolo, Umberto
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (04) : 289 - 297
  • [24] Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience
    Roland Christian Schelker
    Wolfgang Herr
    Albrecht Reichle
    Martin Vogelhuber
    BMC Cancer, 18
  • [25] Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience
    Schelker, Roland Christian
    Herr, Wolfgang
    Reichle, Albrecht
    Vogelhuber, Martin
    BMC CANCER, 2018, 18
  • [26] How I treat elderly patients with diffuse large B-cell lymphoma
    Pfreundschuh, Michael
    BLOOD, 2010, 116 (24) : 5103 - 5110
  • [27] Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients
    Nikolett, Wohner
    Gergely, Varga
    Peter, Szloboda
    Peter, Farkas
    Andras, Masszi
    Laura, Horvath
    Gergely, Szombath
    Judit, Varkonyi
    Szabolcs, Benedek
    Tamas, Masszi
    ORVOSI HETILAP, 2017, 158 (41) : 1642 - 1648
  • [28] Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma
    Coiffier, B
    Salles, G
    BLOOD, 2004, 104 (05) : 1584 - 1585
  • [29] Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma
    Ulu, Bahar Uncu
    Yigenoglu, Tugce Nur
    Basci, Semih
    Bakirtas, Mehmet
    Sahin, Derya
    Darcin, Tahir
    Yaman, Samet
    Bozan, Ersin
    Secilmis, Sema
    Candir, Burcu Arslan
    Yildiz, Jale
    Iskender, Dicle
    Baysal, Nuran Ahu
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    LEUKEMIA RESEARCH, 2021, 110
  • [30] Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma
    Saygin, Caner
    Jia, Xuefei
    Hill, Brian
    Dean, Robert
    Pohlman, Brad
    Smith, Mitchell R.
    Jagadeesh, Deepa
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : 989 - 996
12345